Clinical Trials
4 trialsNCT03280563 2025-11-10
MORPHEUS HR+BC
Hoffmann-La Roche
Phase 1/2 Completed
NCT02871791 2022-08-29
Palbociclib With Everolimus + Exemestane In BC
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT02732119 2021-05-05
TRINITI-1
Novartis
Phase 1/2 Completed
NCT01202591 2016-02-11
GLOW
AstraZeneca
Phase 1/2 Completed